Viral hijacking of human receptors through heterodimerization

Biochemical and Biophysical Research Communications

Volumn 377, Issue 1, 2008, Pages 93-97

  Vischer, Henry F ^a   Nijmeijer, Saskia ^a   Smit, Martine J ^a   Leurs, Rob ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Chemokines; Epstein Barr virus; GPCR; Herpesvirus; Heterodimerization

Indexed keywords

CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR;

ARTICLE; B LYMPHOCYTE; BILF1 GENE; CONTROLLED STUDY; DIMERIZATION; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; VIRUS GENE;

B-LYMPHOCYTES; CELL LINE; CELL MEMBRANE; CELL MOVEMENT; DIMERIZATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPRECIPITATION; LUMINESCENT MEASUREMENTS; RECEPTORS, CHEMOKINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, VIRUS; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 54449096236     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.082     Document Type: Article

References (20)

1. Laichalk L.L., and Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79 (2005) 1296-1307
2. Beisser P.S., Verzijl D., Gruijthuijsen Y.K., Beuken E., Smit M.J., Leurs R., Bruggeman C.A., and Vink C. The Epstein-Barr Virus BILF1 gene encodes a G Protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. J. Virol. 79 (2005) 441-449
3. Kaptein S.J., Losen M., Martinez-Martinez P., Lavreysen H., Vanheel A., De Baets M.H., Bruggeman C.A., Vink C., and Beisser P.S. Generation of polyclonal antibodies directed against G protein-coupled receptors using electroporation-aided DNA immunization. J. Pharmacol. Toxicol. Methods (2007)
4. Paulsen S.J., Rosenkilde M.M., Eugen-Olsen J., and Kledal T.N. Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J. Virol. 79 (2005) 536-546
5. Vischer H.F., Vink C., and Smit M.J. A viral conspiracy: hijacking the chemokine system through virally encoded pirated chemokine receptors. Curr. Top. Microbiol. Immunol. 303 (2006) 121-154
6. Milligan G. G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discov. Today 11 (2006) 541-549
7. Kunkel E.J., and Butcher E.C. Plasma-cell homing. Nat. Rev. Immunol. 3 (2003) 822-829
8. Rosenkilde M.M., Benned-Jensen T., Andersen H., Holst P.J., Kledal T.N., Luttichau H.R., Larsen J.K., Geisler C., Christensen J.P., and Schwartz T.W. Molecular pharmacological phenotyping of EBI2 - an orphan 7TM receptor with constitutive activity. J. Biol. Chem. (2006)
9. Casarosa P., Waldhoer M., LiWang P.J., Vischer H.F., Kledal T., Timmerman H., Schwartz T.W., Smit M.J., and Leurs R. CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. J. Biol. Chem. 280 (2005) 3275-3285
10. van Rijn R.M., Chazot P.L., Shenton F.C., Sansuk K., Bakker R.A., and Leurs R. Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors. Mol. Pharmacol. 70 (2006) 604-615
11. Coward P., Chan S.D., Wada H.G., Humphries G.M., and Conklin B.R. Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors. Anal. Biochem. 270 (1999) 242-248
12. Verzijl D., Storelli S., Scholten D.J., Bosch L., Reinhart T.A., Streblow D.N., Tensen C.P., Fitzsimons C.P., Zaman G.J., Pease J.E., de Esch I.J., Smit M.J., and Leurs R. Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors. J. Pharmacol. Exp. Ther. 325 (2008) 544-555
13. Hulshof J.W., Vischer H.F., Verheij M.H., Fratantoni S.A., Smit M.J., de Esch I.J., and Leurs R. Synthesis and pharmacological characterization of novel inverse agonists acting on the viral-encoded chemokine receptor US28. Bioorg. Med. Chem. 14 (2006) 7213-7230
14. Sekine-Aizawa Y., and Huganir R.L. Imaging of receptor trafficking by using alpha-bungarotoxin-binding-site-tagged receptors. Proc. Natl. Acad. Sci. USA 101 (2004) 17114-17119
15. Maurel D., Kniazeff J., Mathis G., Trinquet E., Pin J.P., and Ansanay H. Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology. Anal. Biochem. 329 (2004) 253-262
16. Mercier J.F., Salahpour A., Angers S., Breit A., and Bouvier M. Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277 (2002) 44925-44931
17. Case R., Sharp E., Benned-Jensen T., Rosenkilde M.M., Davis-Poynter N., and Farrell H.E. Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J. Virol. 82 (2008) 1884-1898
18. El-Asmar L., Springael J.Y., Ballet S., Andrieu E.U., Vassart G., and Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol. Pharmacol. 67 (2005) 460-469
19. Sohy D., Parmentier M., and Springael J.Y. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J. Biol. Chem. 282 (2007) 30062-30069
20. Springael J.Y., Le Minh P.N., Urizar E., Costagliola S., Vassart G., and Parmentier M. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Mol. Pharmacol. 69 (2006) 1652-1661